Capricor Therapeutics CAPR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 28.86 | 107.49 | -0.62 | -29,156 | -30 | |
| 2025Q3 | 7.21 | 106.97 | -0.54 | -26,284 | -25 | |
| 2025Q2 | 9.93 | 106.98 | -0.57 | -27,719 | -26 | |
| 2025Q1 | 9.49 | 102.42 | -0.53 | -24,983 | -24 | |
| 2024Q4 | 13.80 | 108.16 | -0.11 | -7,698 | -7 | |
| 2024Q3 | 15.21 | 103.61 | -0.38 | -13,010 | -13 | |
| 2024Q2 | 4.77 | 105.37 | -0.35 | -11,591 | -11 | |
| 2024Q1 | 6.79 | 104.82 | -0.31 | -10,266 | -10 | |
| 2023Q4 | 4.89 | 168.11 | 0.02 | -1,281 | -1 | |
| 2023Q3 | 3.42 | 107.42 | -0.25 | -6,865 | -6 | |
| 2023Q2 | 4.78 | 105.17 | -0.29 | -7,747 | -7 | |
| 2023Q1 | 4.22 | 105.35 | -0.31 | -8,185 | -8 | |
| 2022Q4 | 3.86 | 104.47 | -0.31 | -8,066 | -8 | |
| 2022Q3 | 6.00 | 101.68 | -0.26 | -6,478 | -6 | |
| 2022Q2 | 3.49 | 102.98 | -0.29 | -7,322 | -7 | |
| 2022Q1 | 3.43 | 100.17 | -0.32 | -7,832 | -8 | |
| 2021Q4 | 2.93 | 103.05 | -0.26 | -6,380 | -6 | |
| 2021Q3 | 4.02 | 109.74 | -0.17 | -4,315 | -4 | |
| 2021Q2 | 5.13 | 107.06 | -0.21 | -5,083 | -5 | |
| 2021Q1 | 4.68 | 100.17 | -0.23 | -5,161 | -5 |